CLDI

Calidi Biotherapeutics, Inc.

1.80 USD

Last updated Nov 29, 09:14 UTC

Yesterday HIGH

$1.94

Yesterday LOW

$1.78

52w HIGH

$13.79

52w LOW

$1.5

EPS

-0.14

PE

-12.86

Next Earnings

Feb 18, 2024

Overview News Government Trades

Calidi Biotherapeutics, Inc. stock is down -11.76% since 30 days ago. The next earnings date is Feb 18, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 2 November’s closed higher than October. 100% of analysts rate it a buy.

First Light Acquisition Group, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and headquartered in Reston, Virginia.

Stock Exchange

NYSE

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

firstlightacquisition.com

Vandana Singh

Mon Oct 9, 2023

Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player

Baird initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI), which uses allogeneic stem cells to deliver oncolytic viruses to tumors for cancer treatment.
Benzinga Insights

Mon Oct 9, 2023

Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
Benzinga Newsdesk

Mon Oct 9, 2023

Baird Initiates Coverage On Calidi Biotherapeutics with Outperform Rating, Announces Price Target of $9

Baird analyst Joel Beatty initiates coverage on Calidi Biotherapeutics (AMEX:CLDI) with a Outperform rating and announces Price Target of $9.
Lisa Levin

Mon Sep 25, 2023

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Lisa Levin

Fri Sep 22, 2023

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Lisa Levin

Wed Sep 20, 2023

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.
Lisa Levin

Wed Sep 13, 2023

Dow Turns Lower; KULR Technology Group Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the Dow Jones falling 100 points on Wednesday. The Dow traded down 0.29% to 34,545.66 while the NASDAQ rose 0.22% to 13,803.43. The S&P 500, also rose, gaining, 0.01% to 4,462.11.
Lisa Levin

Wed Sep 13, 2023

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.
Lisa Levin

Wed Sep 13, 2023

Dow Gains 50 Points; US Crude Oil Inventories Rise

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500, also rose, gaining, 0.30% to 4,475.23.
Lisa Levin

Wed Sep 13, 2023

Nasdaq Gains 50 Points; US Inflation Rate Rises In August

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.11% to 34,685.47 while the NASDAQ rose 0.39% to 13,827.83. The S&P 500, also rose, gaining, 0.25% to 4,473.00.